The second one observed in severe cases a significant increase in SP-D levels on admission, with positive correlation with inflammation markers (C-reactive protein, IL-6), but could not prove the protective role of this protein in COVID-19 (39, 40). This evidence concerns the gene SFTPD and COVID-19.